Coronary Care Caffeine: Influence of Coffee on Heart Rate Post Myocardial Infarction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00137098|
Recruitment Status : Completed
First Posted : August 29, 2005
Last Update Posted : October 5, 2009
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction||Drug: Caffeine||Phase 3|
120 post MI patients on CCU will be studied during the first week of admission. Patients will be categorised using the following criteria: Infarct size and site; PMH; Co-morbidities; Drugs; Regular caffeine ingestion.
Patients will be randomised to receive either caffeinated or de-caffeinated coffee or tea during admission. HRV will be assessed by non-invasive Holter-monitoring on the fifth day. Salivary caffeine concentration will be assessed concurrently to assess compliance.
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Official Title:||Influence of Coffee on Heart Rate Variability Post Myocardial Infarction|
|Study Start Date :||September 2003|
|Study Completion Date :||January 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00137098
|Royal Bournemouth Hospital|
|Bournemouth, Dorset, United Kingdom, BH7 7DW|
|Principal Investigator:||Tristan Richardson, Dr||Royal Bournemouth Hospital|